Pure Global AI
Manufacturer profile

PEARL INC.

BrazilUnited States1 ANVISA registration1 unique technical categoryJun 15, 2026 – Jun 15, 2026
Verified
1
Total products
1
Technical names
Jun 2026
Earliest registration
Jun 2026
Latest registration
Regulatory footprint
Search PEARL INC. across other regulatory registries
ThailandEuropean UnionVietnamSouth KoreaEcuadorUnited States
Recent registrations
Latest 5 products registered by this manufacturer
Software
Second Opinion
Class II · Jun 15, 2026
Most popular products
Products with most registrations
Software
1 registrations
Top registration holders
Companies holding product registrations for this manufacturer
FRDB CONSULTORIA REGULATORIA LTDA.
1 products
Top competitors
Companies with the most overlapping products (same technical names)
PHILIPS MEDICAL SYSTEMS NEDERLAND B.V.
Netherlands
8 registrations1 shared products
Shared products
Software
GE HEALTHCARE IITS USA CORP
United States
6 registrations1 shared products
Shared products
Software
CARDIO SISTEMAS COMERCIAL E INDUSTRIAL LTDA
Brazil
6 registrations1 shared products
Shared products
Software
APPLE INC.
United States
5 registrations1 shared products
Shared products
Software
FRACTUS INDUSTRIA COMERCIO PRODUTOS MEDICOS LTDA
Brazil
5 registrations1 shared products
Shared products
Software
About this profile

Explore comprehensive manufacturer profile for PEARL INC. based in United States through Pure Global AI's free Brazil medical device database. This manufacturer has 1 products registered with ANVISA across 1 unique technical categories. Their regulatory history spans from Jun 15, 2026 to Jun 15, 2026.

This page provides detailed insights including 1 recent product registrations including Software, 1 most popular products with Software having 1 registrations, 1 registration holders including FRDB CONSULTORIA REGULATORIA LTDA., and 5 key competitors with PHILIPS MEDICAL SYSTEMS NEDERLAND B.V. sharing 1 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.